Back to search

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy

Data up to Jan 2025

Published1999
Citations412
References28
Clinical Trials (1)

Total Citations Per Year

Abstract

References (28)

Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

1998 • 9,382 citations

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

1997 • 2,989 citations

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

1997 • 2,670 citations

Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

1997 • 2,154 citations

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

1997 • 2,011 citations

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

1997 • 1,912 citations

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

1997 • 1,911 citations

Early establishment of a pool of latently infected, resting CD4 + T cells during primary HIV-1 infection

1998 • 811 citations

Antigen-independent activation of naive and memory resting T cells by a cytokine combination.

1994 • 541 citations

Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary Study

1995 • 430 citations

Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus

1996 • 406 citations

Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines

1998 • 356 citations

Cellular and Anatomical Reservoirs of HIV-1 in Patients Receiving Potent Antiretroviral Combination Therapy

1998 • 310 citations

CONTROLLED TRIAL OF INTERLEUKIN-2 INFUSIONS IN PATIENTS INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS

1996 • 214 citations

Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein.

1987 • 179 citations

Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity.

1996 • 168 citations

Subcutaneous Administration of Interleukin‐2 in Human Immunodeficiency Virus Type 1—Infected Persons

1997 • 164 citations

Toward HIV Eradication or Remission: The Tasks Ahead

1998 • 162 citations

Dilution assay statistics

1994 • 136 citations

Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment

1997 • 105 citations

Outpatient Continuous Intravenous Interleukin‐2 or Subcutaneous, Polyethylene Glycol‐Modified Interleukin‐2 in Human Immunodeficiency Virus‐Infected Patients: A Randomized, Controlled, Multicenter Study

1998 • 92 citations

Rapid Cytokine Release in Cancer Patients Treated with Interleukin-2

1992 • 40 citations

Exploring How to Get at--and Eradicate--Hidden HIV

1998 • 39 citations

Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens

1998 • 36 citations

Treatment of malignant melanoma and renal cell carcinoma with recombinant human interleukin-2: analysis of cytokine levels in sera and culture supernatants

1992 • 28 citations

Comparison between subcutaneous and intravenous interleukin‐2 treatment in HIV disease

1998 • 24 citations

A National Tissue Bank to Track HIV Eradication and Immune Reconstitution

1998 • 12 citations

Clinical trial of natural human lymphocyte-derived interleukin 2 in cancer patients: Effects on cytokine production and suppressor cell status

1991 • 2 citations

Cited By (0)

Loading...
Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in… (1999) – Nature Medicine | Metascience Observatory Explorer